NASDAQ:IMV IMV (IMV) Stock Price, News & Analysis → Biden’s Tax Plan Could Destroy Your Retirement Savings! (From GoldenCrest Metals) (Ad) Free IMV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.49▼$0.9152-Week Range N/AVolume44,800 shsAverage Volume233,607 shsMarket Capitalization$9.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IMV alerts: Email Address Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. About IMV Stock (NASDAQ:IMV)IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.Read More Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. IMV Stock News HeadlinesMay 29, 2024 | businesswire.comVeristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs TeamMay 27, 2024 | msn.comUnveiling the New Haval H9: A Benchmark for Future SUVsMay 24, 2024 | msn.com50-year-old man held for reckless driving, damaging cars, bikes in BengaluruMay 22, 2024 | finance.yahoo.comImvax concludes enrolment in Phase IIb glioblastoma treatment trialMay 21, 2024 | finance.yahoo.comImvax Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful FinancingMay 20, 2024 | msn.comYouth rides bike with girl sitting on fuel tank, arrestedMay 20, 2024 | msn.comMan in Bengaluru booked for riding bike with a woman in his lap. VIDEOMay 15, 2024 | msn.comIMV-IForest: Advanced Conveyor Roller Fault DetectionMay 10, 2024 | ca.finance.yahoo.comBioVaxys Technology Corp. Closes SECOND Tranche of Private PlacementMay 8, 2024 | finanznachrichten.deInflaRx N.V.: InflaRx Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | msn.comThe Kremlin scores propaganda points with a display of captured tanks and armour ahead of the Victory Day paradeMay 3, 2024 | finance.yahoo.comBioVaxys Technology Corp. Closes First Tranche of Private PlacementMay 2, 2024 | msn.comO.J. Simpson's lawyer ready to meet with Goldman, Brown familiesMay 2, 2024 | msn.comCancer: Monthly horoscope MayApril 30, 2024 | finanznachrichten.deBioVaxys Technology Corp.: Biovaxys Appoints Christopher Cherry As Chief Financial OfficerApril 13, 2024 | msn.comGolden Bachelor news: Gerry and Theresa break up, but still love each otherApril 7, 2024 | msn.comThe Pros And Cons Of Owning Toyota's $13,000 Pickup TruckApril 3, 2024 | msn.comWhy are there so many cars in Omaha without license plates?April 3, 2024 | msn.comVirginia Tech hires Marquette's Megan Duffy as new coachMarch 28, 2024 | finanznachrichten.deCalciMedica, Inc.: CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate UpdatesMarch 27, 2024 | msn.comPhilippines sales up in February 2024March 26, 2024 | msn.comAn Electric Toyota Hilux Is Reportedly Coming by 2025March 26, 2024 | msn.comThe New FJ Cruiser Could Use Toyota's $13,000 Truck PlatformMarch 25, 2024 | theguardian.comAsian hornet may have become established in UK, sighting suggestsMarch 22, 2024 | finanznachrichten.deBioVaxys Technology Corp.: BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENTSee More Headlines Receive IMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMV CUSIPN/A CIK1734768 Webimv-inc.com Phone(902) 492-1819FaxN/AEmployees97Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,990,000.00 Net Margins-11,547.42% Pretax Margin-11,547.42% Return on Equity-12,695.41% Return on Assets-104.84% Debt Debt-to-Equity RatioN/A Current Ratio2.93 Quick Ratio2.93 Sales & Book Value Annual Sales$330,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.69) per share Price / BookN/AMiscellaneous Outstanding Shares11,712,000Free Float11,673,000Market Cap$9.63 million OptionableOptionable Beta0.95 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesAndrew HallChief Executive Office & DirectorJennifer SchmitkeChief Operating OfficerBrittany DavisonChief Accounting Officer, Director & SVP-financeJeremy R. GraffChief Scientific OfficerStéphane FisetVice President-Clinical ResearchKey CompetitorsXilio TherapeuticsNASDAQ:XLOFortress BiotechNASDAQ:FBIOMarker TherapeuticsNASDAQ:MRKRNRx PharmaceuticalsNASDAQ:NRXPEyenoviaNASDAQ:EYENView All Competitors IMV Stock Analysis - Frequently Asked Questions How were IMV's earnings last quarter? IMV Inc. (NASDAQ:IMV) issued its earnings results on Thursday, November, 11th. The company reported ($1.30) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($1.30). The business had revenue of $0.04 million for the quarter. IMV had a negative net margin of 11,547.42% and a negative trailing twelve-month return on equity of 12,695.41%. During the same quarter last year, the company posted ($1.00) EPS. When did IMV's stock split? Shares of IMV reverse split on Tuesday, December 13th 2022. The 1-10 reverse split was announced on Tuesday, December 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. This page (NASDAQ:IMV) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMV Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMV With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.